Cargando…
The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease
Diabetic kidney disease (DKD), an emerging global health issue, is one of the most severe microvascular complications derived from diabetes and a primary pathology contributing to end-stage renal disease. The currently available treatment provides only symptomatic relief and has failed to delay the...
Autores principales: | Tao, Pengyu, Ji, Jing, Wang, Qian, Cui, Mengmeng, Cao, Mingfeng, Xu, Yuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806165/ https://www.ncbi.nlm.nih.gov/pubmed/36601125 http://dx.doi.org/10.3389/fimmu.2022.1080456 |
Ejemplares similares
-
Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017) -
Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
por: Dong, Yue, et al.
Publicado: (2023) -
Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2017) -
Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study
por: Xu, Ruoting, et al.
Publicado: (2020) -
The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
por: Zhong, Chenyu, et al.
Publicado: (2021)